Bioprocessing 4.0 aims to leverage advanced digital technologies, automation, and data-driven...
Bioprocessing 4.0 aims to leverage advanced digital technologies, automation, and data-driven...
Cell line screening and development plays a fundamental role in the biopharmaceutical industry,...
Welcome, dear scientific sleuths, to a tale that will both amuse and enlighten as we unravel the...
revised December 15, 2022
How empowering cell line engineering groups with Culture's cloud...
Get to know Collin Edington, Hardware Engineering Manager at Culture and our first employee. Collin...
While you may be aware that synthetic biology is on the rise, you may not know that there’s a major...
Many of Culture’s clients have questions pertaining to the right time to transition to bioreactors...
Scaling up a bioprocess can be challenging, but thorough preparation for scale-up early in the...
revised December 16, 2022
In addition to the multitude of different biological pathways and ...
revised December 16, 2022
Using dynamic feeds to facilitate successful bioprocess development and...
What could you achieve with more bioreactor capacity?
You’re no longer limited by the bioreactor capacity in your lab.
© Culture Biosciences. All rights reserved.